New Analysis of CRYSTAL Results Supports Patient Selection According to RAS Mutation Status to Maximize Benefit from CET Therapy

Article Information

DOI 
http://dx.doi.org/10.1177/155989771422004
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Toni Rizzo
  1. Eric Van Cutsem, MD
    1. University Hospitals Gasthuisberg/Leuven, Leuven, Belgium
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015210
Jun 2015700
Jul 2015011
Aug 20151500
Sep 20154900
Oct 2015232
Nov 2015401
Total8454

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
New Analysis of CRYSTAL Results Supports Patient Selection According to RAS Mutation Status to Maximize Benefit from CET Therapy
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Oncology Clinical Trials
Gastrointestinal Cancers
Oncology Clinical Trials
Gastrointestinal Cancers